ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,700.30
-0.31%
S&P ASX All Technology
3,078.20
-0.47%
Brent Oil
82.195
0.09%
US Dollar vs AUD
1.51421
0.03%
Bitcoin
66,235.05
-0.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. OptiNose Inc (OPTN)

  7. OptiNose Inc (OPTN) News

OPTN

OptiNose (OPTN)

OptiNose Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPTN
DateTimeSourceHeadlineSymbolCompany
08/06/202406:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
08/06/202406:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
08/06/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
08/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
07/06/202406:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
30/05/202405:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
21/05/202406:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
21/05/202404:33Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:OPTNOptiNose Inc
18/05/202402:00GlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:OPTNOptiNose Inc
14/05/202423:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
14/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
14/05/202421:00GlobeNewswire Inc.Optinose Reports First Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
11/05/202404:56GlobeNewswire Inc.Optinose Announces Reporting Date for First Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
09/05/202421:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
09/05/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
09/05/202421:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
09/05/202421:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
09/05/202421:00GlobeNewswire Inc.Optinose Announces $55 Million Registered Direct OfferingNASDAQ:OPTNOptiNose Inc
25/04/202421:00GlobeNewswire Inc.Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 millionNASDAQ:OPTNOptiNose Inc
05/04/202407:01GlobeNewswire Inc.Optinose to Present at the Needham Virtual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
16/03/202406:34GlobeNewswire Inc.XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal PolypsNASDAQ:OPTNOptiNose Inc
09/03/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
08/03/202408:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OPTNOptiNose Inc
07/03/202423:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OPTNOptiNose Inc
07/03/202423:00GlobeNewswire Inc.Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
07/03/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
01/03/202408:40GlobeNewswire Inc.Optinose Announces Reporting Date for Fourth Quarter 2023 Financial ResultsNASDAQ:OPTNOptiNose Inc
01/03/202408:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
01/03/202408:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
01/03/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
 Showing the most relevant articles for your search:NASDAQ:OPTN

Your Recent History

ASX
WOW
Woolworths
NYSE
DIS
Walt Disney
ASX
ORG
Origin Energy
NASDAQ
MSFT
Microsoft
NASDAQ
TSLA
Tesla
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
FX
GBPAUD
Sterling vs AUD
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
ASX
ANZ
Australia And New Zealan...
PM
XAUUSD
Gold vs US Dollar
ASX
MQG
Macquarie
ASX
CSL
CSL
FTSE
UKX
FTSE 100
ASX
CBA
Commonwealth Bank Of Aus...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved